Literature DB >> 34262160

Using ctDNA to guide immunotherapy for urothelial cancer.

Annette Fenner1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34262160     DOI: 10.1038/s41585-021-00503-y

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN: 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  1 in total

1.  ctDNA guiding adjuvant immunotherapy in urothelial carcinoma.

Authors:  Thomas Powles; Zoe June Assaf; Nicole Davarpanah; Romain Banchereau; Bernadett E Szabados; Kobe C Yuen; Petros Grivas; Maha Hussain; Stephane Oudard; Jürgen E Gschwend; Peter Albers; Daniel Castellano; Hiroyuki Nishiyama; Siamak Daneshmand; Shruti Sharma; Bernhard G Zimmermann; Himanshu Sethi; Alexey Aleshin; Maurizio Perdicchio; Jingbin Zhang; David S Shames; Viraj Degaonkar; Xiaodong Shen; Corey Carter; Carlos Bais; Joaquim Bellmunt; Sanjeev Mariathasan
Journal:  Nature       Date:  2021-06-16       Impact factor: 69.504

  1 in total
  1 in total

Review 1.  Therapeutic targets and biomarkers of tumor immunotherapy: response versus non-response.

Authors:  Dong-Rui Wang; Xian-Lin Wu; Ying-Li Sun
Journal:  Signal Transduct Target Ther       Date:  2022-09-19
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.